- Home
- ABEO vs MGRM Comparison
ABEO vs MGRM Comparison
Compare ABEO & MGRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- MGRM
- Stock Information
- Founded
- ABEO 1974
- MGRM 2016
- Country
- ABEO United States
- MGRM United States
- Employees
- ABEO N/A
- MGRM N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- MGRM Medical/Dental Instruments
- Sector
- ABEO Health Care
- MGRM Health Care
- Exchange
- ABEO Nasdaq
- MGRM Nasdaq
- Market Cap
- ABEO 289.2M
- MGRM 240.1M
- IPO Year
- ABEO 1980
- MGRM N/A
- Fundamental
- Price
- ABEO $5.26
- MGRM $6.00
- Analyst Decision
- ABEO Strong Buy
- MGRM Strong Buy
- Analyst Count
- ABEO 6
- MGRM 1
- Target Price
- ABEO $18.17
- MGRM $5.40
- AVG Volume (30 Days)
- ABEO 1.1M
- MGRM 190.4K
- Earning Date
- ABEO 11-13-2025
- MGRM 11-13-2025
- Dividend Yield
- ABEO N/A
- MGRM N/A
- EPS Growth
- ABEO N/A
- MGRM N/A
- EPS
- ABEO 0.99
- MGRM N/A
- Revenue
- ABEO $400,000.00
- MGRM N/A
- Revenue This Year
- ABEO N/A
- MGRM N/A
- Revenue Next Year
- ABEO $324.71
- MGRM N/A
- P/E Ratio
- ABEO $5.31
- MGRM N/A
- Revenue Growth
- ABEO N/A
- MGRM N/A
- 52 Week Low
- ABEO $3.93
- MGRM $1.92
- 52 Week High
- ABEO $7.54
- MGRM $6.43
- Technical
- Relative Strength Index (RSI)
- ABEO 31.86
- MGRM 62.71
- Support Level
- ABEO $5.19
- MGRM $5.80
- Resistance Level
- ABEO $5.49
- MGRM $5.96
- Average True Range (ATR)
- ABEO 0.19
- MGRM 0.16
- MACD
- ABEO 0.01
- MGRM -0.00
- Stochastic Oscillator
- ABEO 12.84
- MGRM 39.72
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.